Apomorphine and hallucination Patient Reports February 10, 2012

Apomorphine Side Effects Report #4665061-3
Apomorphine side effect was reported by a Health Professional from on May 03, 2005. Male patient, 67 years of age, was diagnosed with parkinson's disease  and was treated with Apomorphine. After drug was administered, patient experienced the following side effects: condition aggravated, confusional state, hallucination, paranoia, restlessness. Apomorphine dosage: 3 MG/HR;IV. During the same period patient was treated with CARBIDOPA AND LEVODOPA. Patient was hospitalized. Patient recovered.

Apomorphine Side Effects Report #5337460-8
Apomorphine side effect was reported by a Physician from ITALY on May 08, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Apomorphine. After drug was administered, patient experienced the following side effects: agitation, anorexia, hallucination, hallucination, visual, paranoia, poor quality sleep, suicide attempt. Apomorphine dosage: (6.4 MG PER HOUR FOR 1 YEAR SUBCUTANEOUS). During the same period patient was treated with APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, LEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Apomorphine Side Effects Report #4740234-X
Apomorphine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 17, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Apomorphine. After drug was administered, patient experienced the following side effects: confusional state, hallucination, hypotension, nausea , skin disorder. Apomorphine dosage: unknown. Patient recovered.

Apomorphine Side Effects Report #5918827-3
Apomorphine side effect was reported by a Health Professional from UNITED KINGDOM on Sept 30, 2008. Female patient, 74 years of age, was treated with Apomorphine. After drug was administered, patient experienced the following side effects: confusional state, hallucination, paranoia. Apomorphine dosage: (260 MG FOR 8 WEEKS [150 MG DURING THE DAY / 110 MG AT NIGHT] SUBCUTANEOUS). During the same period patient was treated with APOMORPHINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.